George Medicines appoints Dr Charmaine Gittleson as Non-Executive Director
July 12, 2021 07:00 ET
|
George Medicines
George Medicines appoints Dr Charmaine Gittleson as Non-Executive Director London, UK, 12 July 2021 – George Medicines, a late-stage drug development company focused on providing innovative and...
George Medicines appoints Dr Charmaine Gittleson as Non-Executive Director
July 12, 2021 02:00 ET
|
George Medicines
George Medicines appoints Dr Charmaine Gittleson as Non-Executive Director London, UK, 12 July 2021 – George Medicines, a late-stage drug development company focused on providing innovative and...
George Medicines initiates two Phase III trials of triple combination candidate to treat hypertension
July 01, 2021 07:00 ET
|
George Medicines
George Medicines initiates two Phase III trials of triple combination candidate to treat hypertension Novel proprietary triple low-dose combination pill has been shown to outperform traditional blood...
George Medicines initiates two Phase III trials of triple combination candidate to treat hypertension
July 01, 2021 02:00 ET
|
George Medicines
George Medicines initiates two Phase III trials of triple combination candidate to treat hypertension Novel proprietary triple low-dose combination pill has been shown to outperform traditional blood...
George Medicines appoints Stefan König as Chief Executive Officer
June 03, 2021 07:00 ET
|
George Medicines
George Medicines appoints Stefan König as Chief Executive Officer Mr König joins to lead late-stage drug development company developing proprietary fixed dose combination therapies for...
George Medicines appoints Stefan König as Chief Executive Officer
June 03, 2021 02:00 ET
|
George Medicines
George Medicines appoints Stefan König as Chief Executive Officer Mr König joins to lead late-stage drug development company developing proprietary fixed dose combination therapies for...